Examples of 'dyslipidaemia' in a sentence
Meaning of "dyslipidaemia"
dyslipidaemia (noun) - Medical term referring to an abnormal amount of lipid particles in the blood, often associated with cardiovascular disease
Show more definitions
- Alternative spelling of dyslipidemia
How to use "dyslipidaemia" in a sentence
Basic
Advanced
dyslipidaemia
Primary hypercholesterolaemia and mixed dyslipidaemia in adults.
Dyslipidaemia is associated with increased risk of cardiovascular diasese.
Primary hypercholesterolaemia and mixed dyslipidaemia.
Dyslipidaemia is associated with increased risk of cardiovascular disease.
Clinical efficacy in primary hypercholesterolaemia and mixed dyslipidaemia.
Dyslipidaemia is a risk factor for arteriosclerosis.
Diet is the basic treatment for all dyslipidaemia.
Used to treat dyslipidaemia or sulfinpyrazone used to treat chronic gout.
Consultation with standard guidelines for management of dyslipidaemia is recommended.
Dyslipidaemia and other risk factors for coronary artery disease.
Weight gain and dyslipidaemia.
Greater psoriasis severity appeared to be associated with higher prevalence of dyslipidaemia.
Compositions for use in the treatment of dyslipidaemia in chronic kidney disease.
Clinical efficacy and safety in primary hypercholesterolaemia and mixed dyslipidaemia.
Statins and fibrates improve the dyslipidaemia but not the lipodystrophy.
See also
Dyslipidaemia is a general term used to describe individuals with aberrant lipoprotein profiles.
Pelzont was studied in four main studies in patients with hypercholesterolaemia or mixed dyslipidaemia.
Treatment of dyslipidaemia.
Tredaptive was studied in four main studies in patients with hypercholesterolaemia or mixed dyslipidaemia.
Primary hypercholesterolaemia and mixed dyslipidaemia Starting dose recommendation.
Trevaclyn was studied in four main studies in patients with hypercholesterolaemia or mixed dyslipidaemia.
Dyslipidaemia ( including hypercholesterolaemia and hypertriglyceridaemia ) has been reported.
Alirocumab also helps to reduce other fatty substances from blood in patients with mixed dyslipidaemia.
Mixed dyslipidaemia characterised by hypertriglyceridaemia and / or low HDL-cholesterol.
This systematic review aims to synthesize evidence for the association between psoriasis and dyslipidaemia.
Such as type 2 diabetes or dyslipidaemia abnormal levels of fat in their blood.
Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia.
In clinical studies, atazanavir has been shown to induce dyslipidaemia to a lesser extent than comparators.
Haematocrit increased Creatinine renal clearance decreased during initial treatment Dyslipidaemia.
Approximately one third of the cases had dyslipidaemia and one fourth had type 1 or 2 diabetes.
Haematocrit increased Creatinine renal clearance decreased Dyslipidaemia.
Treatment of dyslipidemia Mixed dyslipidaemia characterised by hypertriglyceridaemia and / or low HDL-cholesterol.
Long-term efficacy in primary hypercholesterolaemia and mixed dyslipidaemia.
Dyslipidaemia ( including hypercholesterolaemia and hypertriglyceridaemia ) has been reported in patients taking Votubia.
Risk factors such as type 2 diabetes or dyslipidaemia are present.
Dyslipidaemia is often associated, also as a consequence, with diabetes.
Hypercholesterolemia still is an indication, but mainly in combination with such dyslipidaemia.
Dyslipidaemia includes the following preferred terms, dyslipidaemia, hyperlipidaemia, hypercholesterolaemia, and hypertriglyceridaemia.
Diabetes mellitus is frequently associated with obesity, dyslipidaemia and hypertension.
The agent for treatment of dyslipidaemia is a statin, a fibrate, a niacin and / or a cholesterol absorption inhibitor.
Antipsychotics including brexpiprazole have been associated with metabolic changes, including weight gain and dyslipidaemia.
The term dyslipidaemia includes the following diseases, hyperlipidaemia, hyperlipoproteinaemia, hyperchylomicronaemia, hypercholesteraemia, hypoalphalipoproteinemia hypoHDL / LDL-aemia and hypertriglyceridaemia.
The association between insulin resistance and obesity, hypertension and dyslipidaemia is known as syndrome X.
Placebo-controlled phase 3 studies ( on background statin ) in patients with primary hypercholesterolaemia or mixed dyslipidaemia.
Therefore, the malignant nature of dyslipidaemia in T2DM is.
Ezetimibe-controlled phase 3 study ( on background statin ) in patients with primary hypercholesterolaemia or mixed dyslipidaemia.
Elaboration of technical directives on the control of dyslipidaemia ( Department of Environmental Services ) ;.
He received the organ from a 55 year-old obese male with hypertension and dyslipidaemia.
Regarding co-morbidities, we were specially focused on HBP, dyslipidaemia and diabetes mellitus.
Undesirable effects Tabulated list of adverse reactions Metabolism and nutrition disorders Frequency ‘ Not known '', Dyslipidaemia.
